Clinical Trial NCT05116774
Trial
BioCryst – BCX9930-203 REDEEM-1 (NCT05116774)
Clinical trial ID
NCT05116774
Drug name
BCX9930
Company:
BioCryst
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Active, not recruiting
Start
12/2021
Substance
Low molecular compound
Research question
Monotherapy vs C5 inhibitor in pre-treated patients who are still anemic
Delivery method of drug
Oral
Frequency
2 x daily
Clinical trial locations
France Hungary Italy Spain UK